Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Operating Leases (2019 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Operating Leases for 7 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • Quarterly Operating Leases rose 1093.93% to $2.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Sep 2025, up 1093.93% year-over-year, with the annual reading at $166000.0 for FY2024, 78.13% down from the prior year.
  • Operating Leases for Q3 2025 was $2.9 million at Xtant Medical Holdings, up from $2.7 million in the prior quarter.
  • The five-year high for Operating Leases was $2.9 million in Q3 2025, with the low at $121000.0 in Q1 2025.
  • Average Operating Leases over 5 years is $1.0 million, with a median of $842000.0 recorded in 2021.
  • Peak annual rise in Operating Leases hit 1093.93% in 2025, while the deepest fall reached 81.21% in 2025.
  • Over 5 years, Operating Leases stood at $842000.0 in 2021, then increased by 15.44% to $972000.0 in 2022, then decreased by 21.91% to $759000.0 in 2023, then plummeted by 78.13% to $166000.0 in 2024, then soared by 1676.51% to $2.9 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $2.9 million, $2.7 million, and $121000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.